DUBLIN–(BUSINESS WIRE)–The “Europe Negative Pressure Wound Therapy Market – Focused Insights 2023-2028” report has been added to ResearchAndMarkets.com’s offering.
The European negative pressure wound therapy (NPWT) market is projected to reach a value of $880 million by 2028 from $590 million in 2022, growing at a CAGR of 6.9%
This report provides an in-depth analysis of the complete Europe NPWT market. Exhaustive information regarding the shift towards adopting innovative products in Europe.
One of the major reasons for the lower adoption of NPWT products in the market is the need for reimbursement in some European countries. Constant product launches in the market from key vendors to gain market share is included. A constant increase in the number of target population is driving the market.
The economic burden of a wound per year in Europe is approximately $6500-$8000. Healthcare bodies are introducing multiple strategies and regulations to reduce the economic burden and to increase the adoption of advanced products for faster recovery and reducing re-admissions. The awareness among wound care specialists is increasing. Specialty wound care hospitals collaborate with large hospitals providing better care to the patients.
KEY HIGHLIGHTS:
- The number of diabetics, obese patients, and patients with co-morbidities is increasing constantly in Europe. This leads to an increase in pressure ulcers and prolonged healing of wounds. The increasing target population will drive the demand for NPWT in the European market.
- Conventional NPWT market has a higher contribution as it has a higher adoption rate among healthcare professionals. The hospitals and wound care clinics are major end-users of NPWT products and constitute for major market share
- Improper reimbursement for the NPWT is one of the major reasons for the slower adoption of products in developed markets like Italy, France, and the UK
- The awareness among people of wound care is very low. People prefer conventional treatments and choose not to go for advanced treatments. This is a major limitation for the adoption of NPWT treatments in Europe
- There is a constant increase in the number of surgeries performed in European countries. Increasing access to healthcare settings is increasing the number of elective surgeries. This will increase the demand for NPWT products in the market.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 79 |
| Forecast Period | 2022 – 2028 |
| Estimated Market Value (USD) in 2022 | $0.59 Billion |
| Forecasted Market Value (USD) by 2028 | $0.88 Billion |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Europe |
VENDORS
Key Vendors
- Smith+Nephew
- 3M
- Convatech
Other Prominent Vendors
- Alleva medical
- Cardinal Health
- Carilex
- Deroyal
- Genadyne
- Haromed
- Hartmann
- Medela
- Molnlycke
- Lohmann & Rausch
- Talley Group
- Traiage Meditech
MARKET STRUCTURE
- Market Dynamics
- Competitive Landscape
- Key Vendors
- Other Prominent Vendors
- Strategic Recommendations
- Quantitative Summary
- Abbreviations
SEGMENTATION & FORECAST
Product
- Conventional NPWT
- Single Use NPWT
End-User
- Hospitals
- Wound Care Clinics
- ASCs
- Others
Wound Type
- Chronic Wound
- Acute Wound
Country Analysis
- Germany
- France
- UK
- Italy
- Spain
For more information about this report visit https://www.researchandmarkets.com/r/iap1dn
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900